Fintel reports that on June 17, 2025, Wells Fargo downgraded their outlook for Blueprint Medicines (NasdaqGS:BPMC) from ...

This article is more than 4 years old. For those in the market for a hyper-luxurious car, the Mercedes-Maybach S-Class appears to be the right place to look. This stunning new model features ...

The design blueprint that comprises Mercedes-Maybach’s vehicles – particularly its archetypal S-Class – is established as a recognizable silhouette across the globe. With elongated lines and ...

In a world where too much is not enough, Daimler has parachuted in the Mercedes-Maybach S-Class to sit as the pinnacle of its limousine range. Launched on the eve of the Guangzhou auto show ...

Related: 2024 Mercedes-Maybach EQS680 SUV Brings Electrification to Bespoke Brand The Maybach EQS680 SUV is all-new for 2024 and based on the Mercedes-EQ EQS SUV, which itself was new for 2023.

In better times, before Eric and Christine Brauss' real estate empire collapsed, the luxurious Maybach automobiles the Dallas couple owned were symbols of success. "In a Maybach, you're definitely ...

Mercedes-Benz’s ultraluxury Maybach sub-brand has undertaken its first two-seat project of the modern era and turned out the 2026 SL680 Monogram Series. You might also note that this is the ...

The Maybach isn't the most expensive car in the world, but it is the highest-price line of autos made by Mercedes-Benz. The 62S model of the Maybach -- the auto maker's answer to the Rolls-Royce ...

PARIS and CAMBRIDGE, Mass., June 2, 2025 /PRNewswire/ -- Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic ...

Sanofi SA will buy Blueprint Medicines Corp. for $9.1 billion equity value, in a deal that sees the European pharmaceutical firm expand its rare immunological disease portfolio. Sanofi will pay $ ...